VEGFA and vascular neoplasm: The previously-described study by Exertier et al.[30] provided evidence that KIF20A lies downstream of VEGF signaling and mediates essential processes important for physiological and pathological vascular growth; therefore, KIF20A may constitute a potential novel target for anti-vascular tumor therapy.